ORIC Pharmaceuticals Funding & Investors
ORIC Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company discovers and develops novel therapies for the treatment of cancer diseases. ORIC Pharmaceuticals serves customers in the State of California.
oricpharma.comTotal Amount Raised: $283,000,000
ORIC Pharmaceuticals Funding Rounds
Post Ipo Equity
$85,000,000
Post Ipo Equity Investors
EcoR1 CapitalFrazier Life SciencesNextech InvestMontauk VenturesVenrock Healthcare Capital PartnersBoxer CapitalPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
PfizerSeries D
$55,000,000
Series D Investors
Topspin PartnersEcoR1 CapitalHartford HealthCare EndowmentCity Hill VenturesMemorial Sloan Kettering Cancer CenterCorrelation VenturesKravis Investment PartnersArrowMark PartnersThe Column GroupFidelity Management and Research CompanyInvus GroupTaiho VenturesForesite CapitalOrbiMed AdvisorsCasdin CapitalIrving InvestorsSeries C
$50,000,000
Series C Investors
EcoR1 CapitalMemorial Sloan Kettering Cancer CenterKravis Investment PartnersTaiho VenturesNS InvestmentTrinitas CapitalForesite CapitalOrbiMed AdvisorsTopspin FundFidelity Management and Research CompanyThe Column GroupSeries B
$53,000,000
Series B Investors
Topspin PartnersEcoR1 CapitalOrbiMed AdvisorsForesite CapitalKKRThe Column GroupSeries A
$15,000,000
Series A Investors
The Column Group
Funding info provided by Diffbot.